Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
IRMD
— IRadimed Corporation
NASDAQ
FULL STOCK PAGE →
Q2 2026 Earnings Call Summary
JUL 31, 2026
REVENUE
$20.5M
-6.9%
NET MARGIN
25.5%
-1.0 PTS
EPS
$0.41
-10.9%
FREE CASH FLOW
$5.8M
-27.0%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 4
OLDER CALL →